Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: health  medicine  pharmaceuticals  gw  manufacturing  drugs  epileptic  treatment  pills  multivu  8109951  livanova  medical  technology  therapy  health  treatment  drug  vns  epilepsy  multivu  7966451  psa  greg  grunberg  epilepsy  seizures  sunovion  pharmaceuticals  awareness  health  multivu  7685991  aspiresr  vns  therapy  fda  approval  epilepsy  drug  resistant  health  seizures  medication  doctor  multivu  7651751  webmd  medical  marijuana  cannabis  legalization  epilepsy  seizures  treatment  medicine  health  survey  multivu  7040258  baggage  battles  travel  channel  unclaimed  auctions  flea  markets  antiques  memorabilia  competition  multivu  63403  upsher  smith  epilog  sleep  disorders  epilepsy  seizures  symptoms  insomnia  aed  treatment  multivu  59872  upsher  smith  epilepsy  seizure  control  antiepileptic  medicine  aed  epilog  treatment  medicine  health  resource  multivu  epilepsy  treatment  upsher  smith  practice  management  billing  codes  neurology  doctors  medicine  healthcare  multivu  58062  epilepsy  comorbidities  seizures  upsher-smith  aan  meeting  exhibit  neurology  patients  healthcare  multivu  55934  cle  louisiana  driving  under  the  influence  defense  legal  john  gormley  troy  williams  verified  safe  police  court  crime  cle  north  carolina  john  gormley  driving  under  the  influence  lawyer  police 
Search // seizure
Results 1-12 of 14 for ' seizure ' (0 seconds)
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience. To view the multimedia release go to: https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
Categories // Miscellaneous 
Added: 2022 days ago by MultiVuVideos
Runtime: 3m35s | Views: 395 | Comments: 0
Not yet rated
 

 

 

LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world. One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom. “Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.” To view the multimedia release go to: http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Categories // Miscellaneous 
Added: 2219 days ago by MultiVuVideos
Runtime: 5m11s | Views: 523 | Comments: 0
Not yet rated
 

 

 

Let’s get ready to rumble! Auction specialists Billy “The Dealer” Leroy,” Mark “The Hustler” Meyer, and Laurence & Sally Martin – “The Wild Cards,” are back for a new season of Travel Channel’s original series “Baggage Battles” premiering with back-to-back episodes on Tuesday, October 15 at 9:00 p.m. and 9:30 p.m. ET/PT. In season three, the popular weekly half-hour series continues to give viewers a glimpse into the very profitable business of bidding, buying and reselling of unclaimed items from auctions around the world including airport, freight and shipping, estate, police and seizure, and specialty auctions. The stakes are higher for the expert teams of savvy buyers who still don’t know if it’s junk or jackpot until they win the bid. To view Multimedia News Release, go to http://www.multivu.com/mnr/63403-travel-channel-baggage-battles-season-3
Categories // Fashion and Lifestyle 
Added: 3363 days ago by MultiVuVideos
Runtime: 2m38s | Views: 666 | Comments: 0
Not yet rated
 

 

 

Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that its epilepsy-focused educational website, Epilog.us [http://www.Epilog.us], now features a panel discussion of leading experts on the role of rational polytherapy in the treatment of patients with epilepsy, led by Dr. Barry Gidal, Professor of Pharmacy and Neurology/Division Chair, University of Wisconsin. Dr. Gidal also brings forward discussion on the mechanism of action of specific antiepileptic drugs (AEDs). Additional topics include: AED pharmacokinetics; patient adherence and AEDs; and drug interactions. To view Multimedia News Release, go to http://www.multivu.com/mnr/59891-upsher-smith-epilog-us-pharmacodynamics-of-antiepileptic-drugs-aeds
Added: 3615 days ago by MultiVuVideos
Runtime: 3m43s | Views: 1318 | Comments: 1
Not yet rated
 

 

 

Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that subscribers to Epilog.us can now access the latest information related to Practice Management & Epilepsy at http://www.Epilog.us. Led by Dr. Aatif Husain, Director of the Clinical Neurophysiology Fellowship, Professor of Medicine, Division of Neurology, Duke University Medical Center, and Dr. John Stern, Co‐Director of the Seizure Disorder Center and Professor of Neurology at the David Geffen School of Medicine at UCLA, areas of focus include: the importance of billing code accuracy; commonly utilized billing codes in epilepsy and neurology; and epilepsy quality measures from the American Academy of Neurology (AAN). To view Multimedia News Release, go to http://www.multivu.com/mnr/58062-upsher-smith-epilog-us-practice-management-epilepsy-resources-available
Categories // People and Blog  Business 
Added: 3739 days ago by MultiVuVideos
Runtime: 5m29s | Views: 2118 | Comments: 1
Not yet rated
 

 

 

http://www.sbiseminars.com/CLE-LOUISIANA/ - DUI AND SEARCH & SEIZURE DEFENSE BOOTCAMP. Defending DUI & (So-Called)\
Categories // Miscellaneous 
Added: 3985 days ago by johngeltkn
Runtime: 0m30s | Views: 6605 | Comments: 0
Not yet rated
 

 

 

http://www.sbiseminars.com/CLE-NORTH-CAROLINA/ - DUI AND SEARCH & SEIZURE DEFENSE BOOTCAMP. Defending DUI & (So-Called)
Categories // Miscellaneous 
Added: 3985 days ago by johngeltkn
Runtime: 0m30s | Views: 6289 | Comments: 0
Not yet rated
 

 

 

http://www.sbiseminars.com/LOUISIANA-CLE/ - DUI AND SEARCH & SEIZURE DEFENSE BOOTCAMP. Defending DUI & (So-Called)
Categories // Miscellaneous 
Added: 3985 days ago by johngeltkn
Runtime: 0m30s | Views: 5766 | Comments: 0
Not yet rated
 

 

 

http://www.sbiseminars.com/CLE-SOUTH-CAROLINA/ - DUI AND SEARCH & SEIZURE DEFENSE BOOTCAMP. Defending DUI & (So-Called)\
Categories // Miscellaneous 
Added: 3985 days ago by johngeltkn
Runtime: 0m30s | Views: 6413 | Comments: 0
Not yet rated
 

 

 

http://www.sbiseminars.com/NORTH-CAROLINA-CLE/ - DUI AND SEARCH & SEIZURE DEFENSE BOOTCAMP. Defending DUI & (So-Called)
Categories // Miscellaneous 
Added: 3985 days ago by johngeltkn
Runtime: 0m30s | Views: 6874 | Comments: 0
Not yet rated
 

 

 

http://www.sbiseminars.com/SOUTH-CAROLINA-CLE/ - DUI AND SEARCH & SEIZURE DEFENSE BOOTCAMP. Defending DUI & (So-Called)
Categories // Miscellaneous 
Added: 3985 days ago by johngeltkn
Runtime: 0m30s | Views: 7096 | Comments: 0
Not yet rated
 

 

 

The Epilepsy Foundation’s National Epilepsy Awareness Month gets a boost from Paramount Pictures and JJ Abrams’ Bad Robot Productions with a red carpet affair and after party for Morning Glory, starring Harrison Ford, Diane Keaton, and Rachel McAdams. The event benefits TalkAboutIt.org, created by Greg Grunberg (star of the upcoming NBC series ‘LOVE BITES’) in collaboration with the Epilepsy Foundation. Grunberg, the father of a child with epilepsy, and chair of the National Walk for Epilepsy since its inception, joins the Foundation to educate people about seizures, including the proper first aid of never putting anything in the mouth of someone having a seizure. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/epilepsyfoundation/47010/
Added: 4408 days ago by MultiVuVideos
Runtime: 4m24s | Views: 6451 | Comments: 1
Not yet rated
 

 

 

Page 1 of 2  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2022 ClipMoon.com. All rights reserved.